Hannover Medical School - Developmental Therapeutics Review - Q4 2010

Global Markets Direct, December 2010, Pages: 49

Hannover Medical School – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Hannover Medical School – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Hannover Medical School.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Hannover Medical School with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Hannover Medical School’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Hannover Medical School’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Hannover Medical School’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Hannover Medical School in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Hannover Medical School.
- Avoid Intellectual Property Rights related issues.

List of Tables
List of Figures
Hannover Medical School Snapshot
Key Information
Key Facts
Hannover Medical School – Research and Development Overview
Key Therapeutic Areas
Hannover Medical School – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Hannover Medical School – Pipeline Products Glance
Hannover Medical School – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Hannover Medical School Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Hannover Medical School – Drug Profiles
Advagraf
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide
Product Description
Mechanism of Action
R&D Progress
cytarabine + daunorubicin
Product Description
Mechanism of Action
R&D Progress
Cytarabine+ Idarubicin +Etoposide+ Fludarabine +G-CSF
Product Description
Mechanism of Action
R&D Progress
Enoxaparin
Product Description
Mechanism of Action
R&D Progress
Enoxaparin + Taxotere
Product Description
Mechanism of Action
R&D Progress
Everolimus
Product Description
Mechanism of Action
R&D Progress
Moxifloxacin + Metronidazole
Product Description
Mechanism of Action
R&D Progress
Prograf
Product Description
Mechanism of Action
R&D Progress
Recombinant Erythropoietin Alpha
Product Description
Mechanism of Action
R&D Progress
Rituximab
Product Description
Mechanism of Action
R&D Progress
Bromocriptine
Product Description
Mechanism of Action
R&D Progress
filgrastim + asparaginase + cytarabine + daunorubicin hydrochloride + dexamethasone + etoposide + idarubicin + ifosfamide + leucovorin calcium + methotrexate + prednisolone + vindesine
Product Description
Mechanism of Action
R&D Progress
filgrastim + asparaginase + cytarabine + daunorubicin hydrochloride + dexamethasone + etoposide + idarubicin + ifosfamide + leucovorin calcium + methotrexate + prednisolone + vindesine
Product Description
Mechanism of Action
R&D Progress
ivabradine
Product Description
Mechanism of Action
R&D Progress
mHag HA1/ HA2 Peptides Vaccine
Product Description
Mechanism of Action
R&D Progress
Temsirolimus
Product Description
Mechanism of Action
R&D Progress
Hannover Medical School – Pipeline Analysis
Hannover Medical School – Pipeline Products by Therapeutic Class
Hannover Medical School Pipeline Products By Target
Hannover Medical School – Pipeline Products by Route of Administration
Hannover Medical School – Pipeline Products by Molecule Type
Hannover Medical School - Dormant Projects
Hannover Medical School – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Aerospace and Defense Industry - Global Outlook
• Education Services - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Sports and Fitness Nutrition - Global Strategic Business Report
• International Military and Government Helicopter Survey
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles